← FDA Drug Approvals (Drugs@FDA)

ADREVIEW

NDA · New Drug Application · Sponsor: GE HEALTHCARE · Approved 2008-09-19

Drug application

FDA Application #

NDA022290

Application type

New Drug Application

Brand name

ADREVIEW

Generic name

IOBENGUANE I-123

Active ingredients

IOBENGUANE SULFATE I-123

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GE HEALTHCARE

Manufacturer

Medi-Physics Inc.

First approval

2008-09-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown